Eisler Capital (UK)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$6.17M Buy
11,871
+1,712
+17% +$915K 0.03% 340
2024
Q2
$5.51M Sell
10,159
-993
-9% -$525K 0.04% 320
2024
Q1
$5.78M Buy
11,152
+2,494
+29% +$1.24M 0.05% 275
2023
Q4
$4.08M Buy
8,658
+6,806
+367% +$3.15M 0.03% 332
2023
Q3
$806K Buy
+1,852
New +$840K 0.01% 398

Other funds holding ELV

Eisler Capital (UK)'s ELV Position: Q3 2024 in Review

Eisler Capital (UK) increased its Elevance Health (ELV) stake by 30% in Q3 2024, buying an estimated $617K and bringing the position to 5,030 shares worth $2.62M. The position accounts for 0.01% of the portfolio, ranked #422.

Eisler Capital (UK) first reported a position in ELV in Q1 2024 and has held it in 3 quarters since. 1,694 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Eisler Capital (UK) held 5,030 shares of Elevance Health worth $2.62M as of Q3 2024.
  • Eisler Capital (UK) bought 1,155 Elevance Health shares in Q3 2024, an estimated $617K.
  • Elevance Health made up 0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #422 holding.
  • Eisler Capital (UK) first reported a position in Elevance Health in Q1 2024 and has held it in 3 quarters since.
  • 1,694 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.